SEO URLwww.firestrike.ai/deals/penumbra-boston-scientific-acquisition-2026
acquisitionAnnounced · Feb 16, 2026Medical DevicesSource · MagazinesArticle · Factual
Boston Scientific acquires Penumbra
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
$14.5B
Target
Penumbra
Acquirer
Boston Scientific
Full Acquisition
Status
Pending
Boston Scientific agreed to acquire Penumbra. Reported deal value: $14.5B. Status: Pending. Sector: Medical Devices. Target headquarters context: Location not specified.
This page summarizes publicly available information about the transaction as of 2026-02-16. Figures and status may change as filings and press coverage update.
Published Category Medical Devices Latest News Boston Scientific Corporation has entered into a definitive agreement to acquire Penumbra in a cash-and-stock transaction valuing Penumbra at $374 per share, or an enterprise value of about $ 14 .5 billion
Deal timeline
Announced
Feb 16, 2026 · thehealthcaretechnologyreport.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Medical Devices with a reported deal value of $14.5B. Figures and status may change as sources update.
Sources: thehealthcaretechnologyreport.com · Primary article · FireStrike proprietary index